| Complex I deficiency in Persian multiple sclerosis patients HH Kumleh, GH Riazi, M Houshmand, MH Sanati, K Gharagozli, M Shafa Journal of the neurological sciences 243 (1-2), 65-69, 2006 | 47 | 2006 |
| Complex I deficiency in Persian multiple sclerosis patients HH Kumleh, GH Riazi, M Houshmand, MH Sanati, K Gharagozli, M Shafa Journal of the neurological sciences 243 (1-2), 65-69, 2006 | 47 | 2006 |
| Association analysis of intractable epilepsy with C3435T and G2677T/A ABCB1 gene polymorphisms in Iranian patients M Sayyah, F Kamgarpour, M Maleki, M Karimipoor, K Gharagozli, ... Epileptic Disorders 13 (2), 155-165, 2011 | 40 | 2011 |
| Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial K Gharagozli, AA Harandi, S Houshmand, N Akbari, DF Muresanu, ... Journal of medicine and life 10 (3), 153, 2017 | 39 | 2017 |
| Association between ABCB1-T1236C polymorphism and drug-resistant epilepsy in Iranian female patients M Maleki, M Sayyah, F Kamgarpour, M Karimipoor, A Arab, A Rajabi, ... Iranian biomedical journal 14 (3), 89, 2010 | 33 | 2010 |
| Vagus nerve stimulation in drug-resistant epilepsy: the efficacy and adverse effects in a 5-year follow-up study in Iran H Pakdaman, A Amini Harandi, M Abbasi, M Karimi, MA Arami, SA Mosavi, ... Neurological Sciences 37, 1773-1778, 2016 | 30 | 2016 |
| Effectiveness and safety of MLC601 in the treatment of mild to moderate Alzheimer's disease: a multicenter, randomized controlled trial H Pakdaman, AA Harandi, H Hatamian, M Tabatabae, ... Dementia and geriatric cognitive disorders extra 5 (1), 96-106, 2015 | 22 | 2015 |
| Contribution of dopamine neurotransmission in proconvulsant effect of Toxoplasma gondii infection in male mice J Babaie, M Sayyah, P Fard‐Esfahani, M Golkar, K Gharagozli Journal of neuroscience research 95 (10), 1894-1905, 2017 | 19 | 2017 |
| Incidence of anxiety in epilepsy during coronavirus disease (COVID-19) pandemic M Salari, M Etemadifar, K Gharagozli, K Etemad, F Ashrafi, ... Epilepsy & Behavior 112, 107442, 2020 | 17 | 2020 |
| Health-related quality of life in patients with relapsing-remitting multiple sclerosis treated with subcutaneous interferon β-1a in Iran H Pakdaman, A Amini Harandi, K Gharagozli, M Abbasi, A Tabassi, ... International Journal of Neuroscience 127 (6), 501-507, 2017 | 15 | 2017 |
| Epilepsy lifetime prevalence in Iran: a large population-based national survey H Pakdaman, AA Harandi, K Gharagozli, F Alaeddini, A Esfandani, ... Scientific Reports 11 (1), 9437, 2021 | 14 | 2021 |
| Correlation between distribution of muscle weakness, electrophysiological findings and CTG expansion in myotonic dystrophy R Khoshbakht, A Soltanzadeh, B Zamani, S Abdi, K Gharagozli, K Kahrizi, ... Journal of Clinical Neuroscience 21 (7), 1123-1126, 2014 | 14 | 2014 |
| Toxoplasmosis accelerates acquisition of epilepsy in rats undergoing chemical kindling J Babaie, M Sayyah, S Choopani, T Asgari, M Golkar, K Gharagozli Epilepsy Research 135, 137-142, 2017 | 12 | 2017 |
| Efficacy and safety of MLC601 in the treatment of mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled study H Pakdaman, A Amini Harandi, M Abbasi, H Delavar Kasmaei, F Ashrafi, ... Dementia and Geriatric Cognitive Disorders Extra 7 (1), 136-142, 2017 | 12 | 2017 |
| Seroepidemiological study of Toxoplasma gondii infection in a population of Iranian epileptic patients J Babaie, M Sayyah, K Gharagozli, E Mostafavi, M Golkar EXCLI journal 16, 256, 2017 | 11 | 2017 |
| Amyotrophic lateral sclerosis progression: Iran-ALS clinical registry, a multicentre study H Shamshiri, F Fatehi, F Davoudi, E Mir, B Pourmirza, R Abolfazli, ... Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16 (7-8), 506-511, 2015 | 11 | 2015 |
| Efficacy and tolerability of MLC601 in patients with mild to moderate Alzheimer disease who were unable to tolerate or failed to benefit from treatment with rivastigmine AA Harandi, F Ashrafi, M Tabatabaei, A Ghorbani, HR Hatamian, ... British Journal of Medicine and Medical Research 3 (2), 341-350, 2013 | 9 | 2013 |
| A randomized double-blind trial of comparative efficacy and safety of Avonex and CinnoVex for treatment of relapsing-remitting multiple sclerosis H Pakdaman, M Abbasi, K Gharagozli, F Ashrafi, H Delavar Kasmaei, ... Neurological Sciences 39, 2107-2113, 2018 | 7 | 2018 |
| MLC601 in vascular dementia: an efficacy and safety pilot study H Pakdaman, A Amini Harandi, K Gharagozli, M Abbasi, M Ghaffarpour, ... Neuropsychiatric Disease and Treatment, 2551-2557, 2017 | 7 | 2017 |
| Efficacy and safety of MLC601 in patients with mild to moderate Alzheimer disease: an extension 4-year follow-up study H Pakdaman, K Gharagozli, M Abbasi, A Sobhanian, A Bakhshandehpour, ... Dementia and Geriatric Cognitive Disorders Extra 8 (1), 174-179, 2018 | 6 | 2018 |
